Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 20, 2025 09:10 ET | Source: SNS Insider pvt ltd

Pharmaceutical Contract Manufacturing Market Size to Worth USD 300.34 Billion by 2032, Growing at a 7.15% CAGR – SNS Insider

Pune, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Pharmaceutical Contract Manufacturing Market Size & Growth Analysis: According to SNS Insider, The Pharmaceutical Contract Manufacturing Market was...
November 10, 2023 08:28 ET | Source: Research and Markets

Artificial Intelligence Revolutionizes Merchant API Manufacturing as Market Expands at 6.97% CAGR

Dublin, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The "Global Merchant API Market (by Molecular Type, Segment, Type, Type of Synthesis, End-User, & Region): Insights and Forecast with Potential Impact...
June 28, 2018 12:01 ET | Source: PCI Synthesis; Novacap

Novacap completes the acquisition of PCI Synthesis and expands its pharmaceutical offerings in the U.S.

LYON, France and NEWBURYPORT, Mass., June 28, 2018 (GLOBE NEWSWIRE) -- Novacap, a worldwide player in pharmaceutical synthesis and advanced specialties, announced today that it has completed the...
June 20, 2018 12:03 ET | Source: PCI Synthesis; Novacap

Novacap to expand its pharmaceutical offering in the U.S. with the acquisition of PCI Synthesis

LYON, France and NEWBURYPORT, Mass., June 20, 2018 (GLOBE NEWSWIRE) -- Novacap, a worldwide player in pharmaceutical synthesis and advanced specialties, announced today that it has signed an...
January 30, 2018 09:15 ET | Source: PCI Synthesis

PCI Synthesis Submits Patent for Synthesizing Azelaic Acid

NEWBURYPORT, Mass., Jan. 30, 2018 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...
December 18, 2017 09:15 ET | Source: PCI Synthesis

PCI Synthesis Identifies Trends Affecting the Generic Drugs Sector in 2018

NEWBURYPORT, Mass., Dec. 18, 2017 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...
November 15, 2017 10:15 ET | Source: PCI Synthesis

Scott VanderWel Joins PCI Synthesis as Business Development Manager

NEWBURYPORT, Mass., Nov. 15, 2017 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...